Centre for Commercialization of Regenerative Medicine
Registration:
3
of
7
(2022-11-18
to
2023-02-08)
Grant, Contribution or Other Financial Benefit
- Seeking funding from the Strategic Innovation Fund to allow the client to expand regenerative cell and gene therapy manufacturing in Ontario.